Science

AddToAny

Google+ Facebook Twitter Twitter

Blurring boundaries: Ethics and artificial intelligence

With artificial intelligence becoming ever more prominent in biomedical labs and research, biomedical scientist turned ethicist Sarah E Carter looks at the pressing issues.

Artificial intelligence (AI) is increasingly prevalent in all aspects of life, including the biomedical scientist’s laboratory. While a universal definition of AI is still a matter of debate, the Institute of Electrical and Electronics Engineers in the US broadly defines AI as: “The theory and development of computer systems that are able to perform tasks which normally require human intelligence such as, visual perception, speech recognition, learning, decision-making, and natural language processing.”

In the lab, we now see examples of these intelligent computer systems tackling research tasks, such as tissue imaging and data visualisation. They have also pushed the boundaries of what was possible in biomedical research through their ability to model data on a massive scale, allowing researchers to utilise new tools, such as in silico drug development models. As AI use in the lab becomes more pervasive, an increasing number of research groups now employ a data specialist, and more and more computer science courses are requirements of biomedical graduate programmes. It’s clear that the future of biomedical research will be fuelled by data, AI, and computing power.

Please click here to read the full article.

Image Credit | Getty

Related Articles

The lesser horseshoe bat (Rhinolophus hipposideros)-Image Credit | istock-816193242

Bat swarming and immunity

Bats carry some of the deadliest zoonotic diseases that can infect both humans and animals, such as Ebola and COVID-19.

Pancreas or pancreatic cancer with organs and tumors or cancerous cells 3D rendering illustration with male bodyImage Credit | istock-1467893187

Fibroblast cells and pancreatic cancer growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, it is claimed.

brain tumour CREDIT_science photo library

Pores for thought

A team from Nottingham looks at intraoperative molecular diagnosis of brain tumours using nanopore sequencing.

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Top